Aclaris Therapeutics (NASDAQ: ACRS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aclaris Therapeutics (NASDAQ: ACRS) through any online brokerage.
The latest price target for Aclaris Therapeutics (NASDAQ: ACRS) was reported by HC Wainwright & Co. on Wednesday, June 16, 2021. The analyst firm set a price target for 50.00 expecting ACRS to rise to within 12 months (a possible 261.53% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $13.83 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aclaris Therapeutics.
Aclaris Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Aclaris Therapeutics.
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.